Request for Covid-19 Impact Assessment of this Report
The United States Edaravone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Edaravone market, reaching US$ million by the year 2028. As for the Europe Edaravone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Edaravone players cover Mitsubishi Tanabe Pharma, Simcere, Taj Pharmaceuticals Ltd., and Sun Pharmaceutical Industries Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Edaravone market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral Edaravone
Injection Edaravone
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Edaravone Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Edaravone by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Edaravone by Country/Region, 2017, 2022 & 2028
2.2 Edaravone Segment by Type
2.2.1 Oral Edaravone
2.2.2 Injection Edaravone
2.3 Edaravone Sales by Type
2.3.1 Global Edaravone Sales Market Share by Type (2017-2022)
2.3.2 Global Edaravone Revenue and Market Share by Type (2017-2022)
2.3.3 Global Edaravone Sale Price by Type (2017-2022)
2.4 Edaravone Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Edaravone Sales by Application
2.5.1 Global Edaravone Sale Market Share by Application (2017-2022)
2.5.2 Global Edaravone Revenue and Market Share by Application (2017-2022)
2.5.3 Global Edaravone Sale Price by Application (2017-2022)
3 Global Edaravone by Company
3.1 Global Edaravone Breakdown Data by Company
3.1.1 Global Edaravone Annual Sales by Company (2020-2022)
3.1.2 Global Edaravone Sales Market Share by Company (2020-2022)
3.2 Global Edaravone Annual Revenue by Company (2020-2022)
3.2.1 Global Edaravone Revenue by Company (2020-2022)
3.2.2 Global Edaravone Revenue Market Share by Company (2020-2022)
3.3 Global Edaravone Sale Price by Company
3.4 Key Manufacturers Edaravone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Edaravone Product Location Distribution
3.4.2 Players Edaravone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Edaravone by Geographic Region
4.1 World Historic Edaravone Market Size by Geographic Region (2017-2022)
4.1.1 Global Edaravone Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Edaravone Annual Revenue by Geographic Region
4.2 World Historic Edaravone Market Size by Country/Region (2017-2022)
4.2.1 Global Edaravone Annual Sales by Country/Region (2017-2022)
4.2.2 Global Edaravone Annual Revenue by Country/Region
4.3 Americas Edaravone Sales Growth
4.4 APAC Edaravone Sales Growth
4.5 Europe Edaravone Sales Growth
4.6 Middle East & Africa Edaravone Sales Growth
5 Americas
5.1 Americas Edaravone Sales by Country
5.1.1 Americas Edaravone Sales by Country (2017-2022)
5.1.2 Americas Edaravone Revenue by Country (2017-2022)
5.2 Americas Edaravone Sales by Type
5.3 Americas Edaravone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Edaravone Sales by Region
6.1.1 APAC Edaravone Sales by Region (2017-2022)
6.1.2 APAC Edaravone Revenue by Region (2017-2022)
6.2 APAC Edaravone Sales by Type
6.3 APAC Edaravone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Edaravone by Country
7.1.1 Europe Edaravone Sales by Country (2017-2022)
7.1.2 Europe Edaravone Revenue by Country (2017-2022)
7.2 Europe Edaravone Sales by Type
7.3 Europe Edaravone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Edaravone by Country
8.1.1 Middle East & Africa Edaravone Sales by Country (2017-2022)
8.1.2 Middle East & Africa Edaravone Revenue by Country (2017-2022)
8.2 Middle East & Africa Edaravone Sales by Type
8.3 Middle East & Africa Edaravone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edaravone
10.3 Manufacturing Process Analysis of Edaravone
10.4 Industry Chain Structure of Edaravone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Edaravone Distributors
11.3 Edaravone Customer
12 World Forecast Review for Edaravone by Geographic Region
12.1 Global Edaravone Market Size Forecast by Region
12.1.1 Global Edaravone Forecast by Region (2023-2028)
12.1.2 Global Edaravone Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Edaravone Forecast by Type
12.7 Global Edaravone Forecast by Application
13 Key Players Analysis
13.1 Mitsubishi Tanabe Pharma
13.1.1 Mitsubishi Tanabe Pharma Company Information
13.1.2 Mitsubishi Tanabe Pharma Edaravone Product Offered
13.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mitsubishi Tanabe Pharma Main Business Overview
13.1.5 Mitsubishi Tanabe Pharma Latest Developments
13.2 Simcere
13.2.1 Simcere Company Information
13.2.2 Simcere Edaravone Product Offered
13.2.3 Simcere Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Simcere Main Business Overview
13.2.5 Simcere Latest Developments
13.3 Taj Pharmaceuticals Ltd.
13.3.1 Taj Pharmaceuticals Ltd. Company Information
13.3.2 Taj Pharmaceuticals Ltd. Edaravone Product Offered
13.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Taj Pharmaceuticals Ltd. Main Business Overview
13.3.5 Taj Pharmaceuticals Ltd. Latest Developments
13.4 Sun Pharmaceutical Industries Ltd.
13.4.1 Sun Pharmaceutical Industries Ltd. Company Information
13.4.2 Sun Pharmaceutical Industries Ltd. Edaravone Product Offered
13.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
13.4.5 Sun Pharmaceutical Industries Ltd. Latest Developments
13.5 Unichem Laboratories Ltd
13.5.1 Unichem Laboratories Ltd Company Information
13.5.2 Unichem Laboratories Ltd Edaravone Product Offered
13.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Unichem Laboratories Ltd Main Business Overview
13.5.5 Unichem Laboratories Ltd Latest Developments
13.6 UCB India Ltd
13.6.1 UCB India Ltd Company Information
13.6.2 UCB India Ltd Edaravone Product Offered
13.6.3 UCB India Ltd Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 UCB India Ltd Main Business Overview
13.6.5 UCB India Ltd Latest Developments
13.7 Piramal Healthcare
13.7.1 Piramal Healthcare Company Information
13.7.2 Piramal Healthcare Edaravone Product Offered
13.7.3 Piramal Healthcare Edaravone Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Piramal Healthcare Main Business Overview
13.7.5 Piramal Healthcare Latest Developments
14 Research Findings and Conclusion
Table 1. Edaravone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Edaravone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Edaravone
Table 4. Major Players of Injection Edaravone
Table 5. Global Edaravone Sales by Type (2017-2022) & (K Units)
Table 6. Global Edaravone Sales Market Share by Type (2017-2022)
Table 7. Global Edaravone Revenue by Type (2017-2022) & ($ million)
Table 8. Global Edaravone Revenue Market Share by Type (2017-2022)
Table 9. Global Edaravone Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Edaravone Sales by Application (2017-2022) & (K Units)
Table 11. Global Edaravone Sales Market Share by Application (2017-2022)
Table 12. Global Edaravone Revenue by Application (2017-2022)
Table 13. Global Edaravone Revenue Market Share by Application (2017-2022)
Table 14. Global Edaravone Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Edaravone Sales by Company (2020-2022) & (K Units)
Table 16. Global Edaravone Sales Market Share by Company (2020-2022)
Table 17. Global Edaravone Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Edaravone Revenue Market Share by Company (2020-2022)
Table 19. Global Edaravone Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Edaravone Producing Area Distribution and Sales Area
Table 21. Players Edaravone Products Offered
Table 22. Edaravone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Edaravone Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Edaravone Sales Market Share Geographic Region (2017-2022)
Table 27. Global Edaravone Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Edaravone Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Edaravone Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Edaravone Sales Market Share by Country/Region (2017-2022)
Table 31. Global Edaravone Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Edaravone Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Edaravone Sales by Country (2017-2022) & (K Units)
Table 34. Americas Edaravone Sales Market Share by Country (2017-2022)
Table 35. Americas Edaravone Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Edaravone Revenue Market Share by Country (2017-2022)
Table 37. Americas Edaravone Sales by Type (2017-2022) & (K Units)
Table 38. Americas Edaravone Sales Market Share by Type (2017-2022)
Table 39. Americas Edaravone Sales by Application (2017-2022) & (K Units)
Table 40. Americas Edaravone Sales Market Share by Application (2017-2022)
Table 41. APAC Edaravone Sales by Region (2017-2022) & (K Units)
Table 42. APAC Edaravone Sales Market Share by Region (2017-2022)
Table 43. APAC Edaravone Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Edaravone Revenue Market Share by Region (2017-2022)
Table 45. APAC Edaravone Sales by Type (2017-2022) & (K Units)
Table 46. APAC Edaravone Sales Market Share by Type (2017-2022)
Table 47. APAC Edaravone Sales by Application (2017-2022) & (K Units)
Table 48. APAC Edaravone Sales Market Share by Application (2017-2022)
Table 49. Europe Edaravone Sales by Country (2017-2022) & (K Units)
Table 50. Europe Edaravone Sales Market Share by Country (2017-2022)
Table 51. Europe Edaravone Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Edaravone Revenue Market Share by Country (2017-2022)
Table 53. Europe Edaravone Sales by Type (2017-2022) & (K Units)
Table 54. Europe Edaravone Sales Market Share by Type (2017-2022)
Table 55. Europe Edaravone Sales by Application (2017-2022) & (K Units)
Table 56. Europe Edaravone Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Edaravone Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Edaravone Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Edaravone Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Edaravone Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Edaravone Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Edaravone Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Edaravone Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Edaravone Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Edaravone
Table 66. Key Market Challenges & Risks of Edaravone
Table 67. Key Industry Trends of Edaravone
Table 68. Edaravone Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Edaravone Distributors List
Table 71. Edaravone Customer List
Table 72. Global Edaravone Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Edaravone Sales Market Forecast by Region
Table 74. Global Edaravone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Edaravone Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Edaravone Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Edaravone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Edaravone Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Edaravone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Edaravone Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Edaravone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Edaravone Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Edaravone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Edaravone Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Edaravone Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Edaravone Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Edaravone Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Edaravone Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Edaravone Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Edaravone Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Edaravone Revenue Market Share Forecast by Application (2023-2028)
Table 92. Mitsubishi Tanabe Pharma Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 93. Mitsubishi Tanabe Pharma Edaravone Product Offered
Table 94. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Mitsubishi Tanabe Pharma Main Business
Table 96. Mitsubishi Tanabe Pharma Latest Developments
Table 97. Simcere Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 98. Simcere Edaravone Product Offered
Table 99. Simcere Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Simcere Main Business
Table 101. Simcere Latest Developments
Table 102. Taj Pharmaceuticals Ltd. Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 103. Taj Pharmaceuticals Ltd. Edaravone Product Offered
Table 104. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Taj Pharmaceuticals Ltd. Main Business
Table 106. Taj Pharmaceuticals Ltd. Latest Developments
Table 107. Sun Pharmaceutical Industries Ltd. Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceutical Industries Ltd. Edaravone Product Offered
Table 109. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Sun Pharmaceutical Industries Ltd. Main Business
Table 111. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 112. Unichem Laboratories Ltd Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 113. Unichem Laboratories Ltd Edaravone Product Offered
Table 114. Unichem Laboratories Ltd Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Unichem Laboratories Ltd Main Business
Table 116. Unichem Laboratories Ltd Latest Developments
Table 117. UCB India Ltd Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 118. UCB India Ltd Edaravone Product Offered
Table 119. UCB India Ltd Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. UCB India Ltd Main Business
Table 121. UCB India Ltd Latest Developments
Table 122. Piramal Healthcare Basic Information, Edaravone Manufacturing Base, Sales Area and Its Competitors
Table 123. Piramal Healthcare Edaravone Product Offered
Table 124. Piramal Healthcare Edaravone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Piramal Healthcare Main Business
Table 126. Piramal Healthcare Latest Developments
List of Figures
Figure 1. Picture of Edaravone
Figure 2. Edaravone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edaravone Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Edaravone Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Edaravone Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Edaravone
Figure 10. Product Picture of Injection Edaravone
Figure 11. Global Edaravone Sales Market Share by Type in 2021
Figure 12. Global Edaravone Revenue Market Share by Type (2017-2022)
Figure 13. Edaravone Consumed in Hospital
Figure 14. Global Edaravone Market: Hospital (2017-2022) & (K Units)
Figure 15. Edaravone Consumed in Clinic
Figure 16. Global Edaravone Market: Clinic (2017-2022) & (K Units)
Figure 17. Edaravone Consumed in Others
Figure 18. Global Edaravone Market: Others (2017-2022) & (K Units)
Figure 19. Global Edaravone Sales Market Share by Application (2017-2022)
Figure 20. Global Edaravone Revenue Market Share by Application in 2021
Figure 21. Edaravone Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Edaravone Revenue Market Share by Company in 2021
Figure 23. Global Edaravone Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Edaravone Revenue Market Share by Geographic Region in 2021
Figure 25. Global Edaravone Sales Market Share by Region (2017-2022)
Figure 26. Global Edaravone Revenue Market Share by Country/Region in 2021
Figure 27. Americas Edaravone Sales 2017-2022 (K Units)
Figure 28. Americas Edaravone Revenue 2017-2022 ($ Millions)
Figure 29. APAC Edaravone Sales 2017-2022 (K Units)
Figure 30. APAC Edaravone Revenue 2017-2022 ($ Millions)
Figure 31. Europe Edaravone Sales 2017-2022 (K Units)
Figure 32. Europe Edaravone Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Edaravone Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Edaravone Revenue 2017-2022 ($ Millions)
Figure 35. Americas Edaravone Sales Market Share by Country in 2021
Figure 36. Americas Edaravone Revenue Market Share by Country in 2021
Figure 37. United States Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Edaravone Sales Market Share by Region in 2021
Figure 42. APAC Edaravone Revenue Market Share by Regions in 2021
Figure 43. China Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Edaravone Sales Market Share by Country in 2021
Figure 50. Europe Edaravone Revenue Market Share by Country in 2021
Figure 51. Germany Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Edaravone Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Edaravone Revenue Market Share by Country in 2021
Figure 58. Egypt Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Edaravone Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Edaravone in 2021
Figure 64. Manufacturing Process Analysis of Edaravone
Figure 65. Industry Chain Structure of Edaravone
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...